Bausch Health Companies Inc

NYSE:BHC

加拿大 / 医疗保健 / 制药

概况

股息

10年历史财务状况

股票价格

6.48 USD


Key Metrics	Latest
Total Revenue	9.625 B
Adjusted EBITDA	3.134 B
EBITDA Margin	32.6%
Net Profit Margin	1.5%
Total Assets	26.523 B
Total Debt	21.839 B

10Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending										Latest
(in millions)	Dec-15	Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months

Revenue	10,442	9,674	8,724	8,380	8,601	8,027	8,434	8,124	8,757	9,625	9,625
% Growth		-7.4%	-9.8%	-3.9%	2.6%	-6.7%	5.1%	-3.7%	7.8%	9.9%

Adjusted EBITDA	5,105	4,071	3,413	3,319	3,417	3,138	3,260	2,878	2,885	3,134	3,134
% Margin	48.9%	42.1%	39.1%	39.6%	39.7%	39.1%	38.7%	35.4%	32.9%	32.6%	32.6%

Adjusted EBIT	2,638	1,205	555	500	1,342	1,313	1,708	1,484	1,621	1,867	1,867
% Margin	25.3%	12.5%	6.4%	6.0%	15.6%	16.4%	20.3%	18.3%	18.5%	19.4%	19.4%

Adjusted Net Income	549	(1,097)	2,830	(1,922)	(609)	(44)	40	(97)	(125)	149	149
% Margin	5.3%	-11.3%	32.4%	-22.9%	-7.1%	-0.5%	0.5%	-1.2%	-1.4%	1.5%	1.5%

Adjusted Basic EPS	1.60	(3.16)	8.08	(5.47)	(1.73)	(0.12)	0.11	(0.27)	(0.34)	0.40	0.40

支持的计算方式

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
											Original
USD	Fiscal Year Ending										Latest
(in millions)	Dec-15	Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Dec-24
	FY - 9	FY - 8	FY - 7	FY - 6	FY - 5	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM

Revenue	10,442	9,674	8,724	8,380	8,601	8,027	8,434	8,124	8,757	9,625	9,625
% Growth	NA	-7.4%	-9.8%	-3.9%	2.6%	-6.7%	5.1%	-3.7%	7.8%	9.9%

Cost of Revenue	(2,446)	(2,573)	(2,548)	(2,351)	(2,350)	(2,249)	(2,394)	(2,364)	(2,559)	(2,782)	(2,782)
Gross Profit	7,996	7,101	6,176	6,029	6,251	5,778	6,040	5,760	6,198	6,843	6,843
% Revenue	76.6%	73.4%	70.8%	71.9%	72.7%	72.0%	71.6%	70.9%	70.8%	71.1%	71.1%

Research and Development	(440)	(469)	(369)	(442)	(516)	(485)	(473)	(530)	(604)	(634)	(634)
Selling and Marketing	(652)	(564)	(462)	(481)	(544)	(451)	(515)	(518)	(625)	(786)	(786)
General and Admin	(2,048)	(2,218)	(2,120)	(1,992)	(2,010)	(1,916)	(1,977)	(2,013)	(2,270)	(2,497)	(2,497)
Other Inc / (Exp)	(3,452)	(4,457)	(3,138)	(5,594)	(3,418)	(2,339)	(2,680)	(1,378)	(1,787)	(1,404)	(1,404)
Total Operating Exp	(6,592)	(7,708)	(6,089)	(8,509)	(6,488)	(5,191)	(5,645)	(4,439)	(5,286)	(5,321)	(5,321)

Operating Income	1,404	(607)	87	(2,480)	(237)	587	395	1,321	912	1,522	1,522
% Revenue	13.4%	-6.3%	1.0%	-29.6%	-2.8%	7.3%	4.7%	16.3%	10.4%	15.8%	15.8%

Interest Expense	(1,559)	(1,828)	(1,828)	(1,674)	(1,600)	(1,521)	(1,419)	(1,450)	(1,302)	(1,355)	(1,355)
Pre-tax Income	(155)	(2,435)	(1,741)	(4,154)	(1,837)	(934)	(1,024)	(129)	(390)	167	167
Earnings of Discontinued Ops.	0	0	0	0	0	0	0	0	0	0	0
Provision for Taxes	(133)	27	4,145	10	54	375	87	(83)	(221)	(239)	(239)
Net Income to Company	(288)	(2,408)	2,404	(4,144)	(1,783)	(559)	(937)	(212)	(611)	(72)	(72)
% Margin	-2.8%	-24.9%	27.6%	-49.5%	-20.7%	-7.0%	-11.1%	-2.6%	-7.0%	-0.7%	-0.7%

Minority Interest in Earnings	(4)	(1)	0	(4)	(5)	(1)	(11)	(13)	19	26	26
Net Income to Stockholders	(292)	(2,409)	2,404	(4,148)	(1,788)	(560)	(948)	(225)	(592)	(46)	(46)

Preferred Dividends	0	0	0	0	0	0	0	0	0	0	0
Other Adj.	0	0	0	0	0	0	0	0	0	0	0

Net Income to Common	(292)	(2,409)	2,404	(4,148)	(1,788)	(560)	(948)	(225)	(592)	(46)	(46)
% Margin	-2.8%	-24.9%	27.6%	-49.5%	-20.8%	-7.0%	-11.2%	-2.8%	-6.8%	-0.5%	-0.5%

As Reported
Basic EPS (Continuing Ops)	(0.85)	(6.94)	6.86	(11.81)	(5.08)	(1.58)	(2.64)	(0.62)	(1.62)	(0.13)	(0.13)
Diluted EPS (Continuing Ops)	(0.85)	(6.94)	6.83	(11.81)	(5.08)	(1.58)	(2.64)	(0.62)	(1.62)	(0.13)	(0.13)

WA Basic Shares Out.	342.70	347.30	350.20	351.30	352.10	355.00	358.90	362.00	364.90	368.00	368.00
WA Diluted Shares Out.	342.70	347.30	351.80	351.30	352.10	355.00	358.90	362.00	364.90	368.00	368.00

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	(155)	(2,435)	(1,741)	(4,154)	(1,837)	(934)	(1,024)	(129)	(390)	167	167
Addback: Net Interest Expense	1,559	1,828	1,828	1,674	1,600	1,521	1,419	1,450	1,302	1,355	1,355
Addback: Other Non Operating Expenses, Total	103	41	(107)	(23)	(8)	30	(7)	8	52	47	47
Addback: Depreciation & Amortization	2,467	2,866	2,858	2,819	2,075	1,825	1,552	1,394	1,264	1,267	1,267
Addback: Restructuring Charges	0	0	95	77	36	23	73	68	71	32	32
Addback: Merger / Acquisition Expenses	679	170	52	1	8	0	0	0	24	4	4
Addback: Goodwill Impairment	0	1,077	312	2,322	0	0	469	824	493	0	0
Addback: Gain (Loss) On Sale Of Invest.	0	0	0	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Assets	8	323	(216)	6	(31)	(1)	(2)	(5)	(3)	(10)	(10)
Addback: Asset Writedown	304	99	265	485	66	112	211	10	45	29	29
Addback: In Process R&D Expenses	106	48	8	29	45	33	8	1	0	18	18
Addback: Insurance Settlements	0	0	0	0	0	0	0	0	(53)	0	0
Addback: Legal Settlements	37	59	226	(27)	1,401	422	356	9	0	220	220
Addback: Other Unusual Items	(3)	(5)	(167)	110	62	107	205	(752)	80	5	5
Adjusted EBITDA	5,105	4,071	3,413	3,319	3,417	3,138	3,260	2,878	2,885	3,134	3,134
% Margin	48.9%	42.1%	39.1%	39.6%	39.7%	39.1%	38.7%	35.4%	32.9%	32.6%	32.6%

Adjusted EBIT	2,638	1,205	555	500	1,342	1,313	1,708	1,484	1,621	1,867	1,867
% Margin	25.3%	12.5%	6.4%	6.0%	15.6%	16.4%	20.3%	18.3%	18.5%	19.4%	19.4%

Adjusted Net Income Reconciliation
Net Income to Company	(288)	(2,408)	2,404	(4,144)	(1,783)	(559)	(937)	(212)	(611)	(72)	(72)
Addback: Unusual Items	1,131	1,771	575	3,003	1,587	696	1,320	155	657	298	298
Less: Tax Benefit of Unusual Items (26%)	(294)	(460)	(150)	(781)	(413)	(181)	(343)	(40)	(171)	(77)	(77)
Adjusted Net Income	549	(1,097)	2,830	(1,922)	(609)	(44)	40	(97)	(125)	149	149
% Margin	5.3%	-11.3%	32.4%	-22.9%	-7.1%	-0.5%	0.5%	-1.2%	-1.4%	1.5%	1.5%

加载出错

Bausch Health Companies Inc

NYSE:BHC

加拿大 / 医疗保健 / 制药

10年历史财务状况